Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma

Pediatric Blood and Cancer

Volumn 58, Issue 6, 2012, Pages 860-864

  Paulino, Arnold C ^a,b   Margolin, Judith ^b   Dreyer, Zoann ^b   Teh, Bin S ^a   Chiang, Stephen ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Hodgkin disease; Lymphoma; Pediatric cancer; PET CT; Radiotherapy planning

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; GALLIUM; PREDNISONE; VINBLASTINE; VINCRISTINE;

ABDOMEN; ADOLESCENT; ADULT; ARTICLE; BONE MARROW BIOPSY; BONE SCINTISCANNING; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HODGKIN DISEASE; HUMAN; INGUINAL LYMPH NODE; INVOLVED FIELD RADIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MULTIPLE CYCLE TREATMENT; NECK; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SPLEEN; THORAX;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COMBINED MODALITY THERAPY; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84858667219     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23273     Document Type: Article

References (15)

1. Hodgson DC, Hudson MM, Constine LS. Pediatric Hodgkin lymphoma: Maximizing efficacy and minimizing toxicity. Semin Radiat Oncol 2007; 17: 230-242.
2. Hutchings M, Loft A, Hansen M, et al. Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 2006; 91: 482-489.
3. [18F]Fluorodeoxyglucose positron tomography in pediatric Hodgkin's lymphoma: Analysis of a prospective multicenter trial. J Clin Oncol 2009; 27: 4385-4391.
4. Metwally H, Courbon F, David I, et al. Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition. Int J Radiat Oncol Biol Phys 2011; 80: 793-799.
5. Robertson VL, Anderson CS, Keller FG, et al. Role of FDG-PET in the definition of involved-field radiation therapy and management for pediatric Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2011; 80: 324-332.
6. Paulino AC. PET-CT in radiotherapy treatment planning. In: Paulino AC, Teh BS, editors. PET-CT in radiotherapy treatment planning. Philadelphia, Pennsylvania: Saunders, Elsevier, Inc.; 2008. pp. 3-15.
7. Hueltenschmidt B, Sautter-Bihl ML, Lang O, et al. Whole body positron emission tomography in the treatment of Hodgkin disease. Cancer 2001; 91: 302-310.
8. Hudson MM, Krasin MJ, Kaste SC. PET imaging in pediatric Hodgkin's lymphoma. Pediatr Radiol 2004; 34: 190-198.
9. Hernandez-Pamploni M, Takalbar A, Yu JQ, et al. F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatr Radiol 2006; 36: 524-531.
10. 18F-FDG PET in pediatric lymphomas: A comparison with conventional imaging. Cancer Biother Radiopharm 2008; 23: 1-9.
11. Freudenberg LS, Antoch G, Schutt P, et al. FDG-PET/CT in re-staging of patients with lymphoma. Eur J Nucl Med Mol Imaging 2004; 31: 325-329.
12. Hutchings M, Loft A, Hansen M, et al. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. Eur J Haematol 2007; 78: 206-212.
13. Campbell BA, Voss N, Pickles T, et al. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: A question of field size. J Clin Oncol 2008; 26: 5170-5174.
14. Eich HT, Muller RP, Engenhart-Cabillic R, et al. Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol 2008; 184: 406-410.
15. Girinsky T, Specht L, Ghalibafian M, et al. The conundrum of Hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines. Radiother Oncol 2008; 88: 202-210.